510(k) Report

510(k) · Cleared

Cleared

Incstar Cytomegalovirus Igg Elisa Assay

K955361510(k) TraditionalCleared Jul 22, 1996243-day reviewClass II21 CFR 866.3175

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Incstar Corp. · LFZ Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus

Cleared on Jul 22, 1996 as substantially equivalent to K915892 (Gull Laboratories, Inc., 1992) after a 243-day review. Its family tree reaches back 1 generation to 1992. 4 later devices descend from it.

Decided
Jul 22, 1996
Review
243 days
Class
Class II
Product code
LFZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K915892 (1992). 4 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2016: 2 descendants cleared2017: 1 descendant clearedK915892 · CMV Igg Elisa Test · Gull Laboratories, Inc. · 19921990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 3 descendants K915892 · CMV Igg Elisa Test · Gull Laboratories, Inc. · 19920
  1. Root · 1 generation backK915892 CMV Igg Elisa TestGull Laboratories, Inc. · 1992
  2. This deviceK955361 Incstar Cytomegalovirus Igg Elisa AssayIncstar Corp. · 1996
  3. Descendant · cites it directly · 3 of its ownK040290 Diasorin Liaison CMV Igm/IggDiasorin S.P.A · 2005
  4. Descendant · 2 generations on · 0 of its ownK162969 LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control SetDiaSorin, Inc. · 2017
  5. Descendant · 2 generations on · 0 of its ownK161526 LIAISON CMV IgM Serum Control SetDiaSorin, Inc. · 2016
  6. Descendant · 2 generations on · 0 of its ownK161522 LIAISON EBV IgM Serum Control SetDiaSorin, Inc. · 2016

Most influential descendants

Showing 4 of 4 · See all
  • K040290Diasorin Liaison CMV Igm/IggDiasorin S.P.A · 2005 · cites it directly3descendants
  • K162969LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control SetDiaSorin, Inc. · 2017 · 2 generations on0descendants
  • K161526LIAISON CMV IgM Serum Control SetDiaSorin, Inc. · 2016 · 2 generations on0descendants
  • K161522LIAISON EBV IgM Serum Control SetDiaSorin, Inc. · 2016 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K915892CMV Igg Elisa TestGull Laboratories, Inc.1992—
0 (this device)K955361Incstar Cytomegalovirus Igg Elisa AssayIncstar Corp.1996—
+1K040290Diasorin Liaison CMV Igm/IggDiasorin S.P.A2005—
+2K162969LIAISON® CMV IgG and LIAISON® CMV IgG Serum Control SetDiaSorin, Inc.2017—
+2K161526LIAISON CMV IgM Serum Control SetDiaSorin, Inc.2016—
+2K161522LIAISON EBV IgM Serum Control SetDiaSorin, Inc.2016—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
201620
201710
FIG. 1 — Lineage of K955361, 1992–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LFZ device

  1. #1 K220911 Elecsys CMV IgGscore 4.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K915892CMV Igg Elisa Test
Summary page 2
…n present in the reaction solution. SAFETY AND EFFECTIVENESS: The INCSTAR CMV IgG ELISA Kit is substantially equivalent (SE) to the GULL CMV IgG ELISA test, 510(k) No. K915892, which has been cleared by the FDA and is currently in U.S. commercial distribution. In clinical performance studies, 308 serum…
Gull Laboratories, Inc.1992—

Also cleared against K915892: 1 other device →

What descends from it? (4)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K040290Diasorin Liaison CMV Igm/IggDiasorin S.P.A20053

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K040290 (Diasorin S.P.A, 2005) has gone furthest, with 3 descendants of its own.
  • 1 other device also cites its predicate K915892.

How does its category compare?

All LFZ devices

LFZ Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFZ

2in 2022

2014: 22017: 22018: 12022: 2
2007high 2 (2014) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFZ

Too few LFZ 510(k)s in any year since 2007 to give a median.

Recalls per year · LFZ

1in 2025

2007: 12009: 12022: 12025: 1
2007high 1 (2007) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFZ

53in 2025

2007: 72008: 72009: 142010: 32011: 72013: 12014: 32015: 72016: 142017: 132018: 92019: 102020: 72021: 232022: 112023: 362024: 342025: 53
2007high 53 (2025) · low 0 (2012)2025

MAUDE reports naming product code LFZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—17
20080—07
20090—114
20100—03
20110—07
20120—00
20130—01
20142—03
20150—07
20160—014
20172—013
20181—09
20190—010
20200—07
20210—023
20222—111
20230—036
20240—034
20250—153
20260—0—

What is it indicated for?

The INCSTAR CMV IgG ELISA Kit contains instructions and materials for the qualitative and/or semi-quantitative detection of 1gG antibodies to cytomegalovirus in human serum by indirect enzyme-linked immunosorbent assay (ELISA) technique. When performed according to instructions, the CMV IgG ELISA test is of value in the determination of immunological response to infection with CMV. The evaluation of paired sera, acute and convalescent, by demonstrating seroconversion or a significant rise in antibody can aid in the diagnosis of primary infection, reactivated infection, or reinfection with cytomegalovirus.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K955361: Incstar Cytomegalovirus Igg Elisa Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K955361

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026